Health facility characteristics by country; PEARL Facility Survey, 2007–2009.

£<p>: <b>Note that this item is not related to HIV, but to maternal and infant health in general.</b></p><p>*Survey was conducted in delivery facilities where antenatal activities are implemented.</p><p>IQR: Interquartile range.</p

Relationship between composite ANC score and PMTCT coverage.

<p>PEARL Facility Survey, 2007–2009.</p

Antenatal care service provision among observed patients, by country; PEARL Facility Survey, 2007–2009^†.

<p>CBS: Cord blood specimens, IQR: Interquartile range, std: standard deviation.</p><p>**full coverage defined as the proportion of HIV-exposed infants in the sample with both maternal nevirapine ingestion (confirmed by cord blood chromatography) and infant nevirapine ingestion (confirmed by direct observation).</p>†<p>For the direct observation patient measures we first calculated the percent observed at each facility among the up to 6 cases and then computed <u>the mean (and standard deviation)</u> of those facility-level percents to get the overall country values shown in the table.</p

Health facility quality scores and correlation with PMTCT coverage, PEARL Facility Survey, 2007–2009.

<p>ρ: Pearson correlation coefficient, IQR: Interquartile range.</p><p>*p-value for univariate regression models treating coverage as a continuous measure, using GEE to account for correlation due to clustering of facilities within countries.</p

Episodes of <i>P. falciparum</i> malaria (positive on-site smear or RDT, or positive <i>Pf</i> Histidine-rich Protein-2 (<i>Pf</i>HRP2) antigen test) in the 6 malaria-endemic study sites.

<p>Episodes of <i>P. falciparum</i> malaria (positive on-site smear or RDT, or positive <i>Pf</i> Histidine-rich Protein-2 (<i>Pf</i>HRP2) antigen test) in the 6 malaria-endemic study sites.</p

Malaria diagnoses made at the four sites where malaria was detected by blood smear (on-site testing), RDT (on-site testing) or <i>Pf</i> Histidine-rich Protein-2 (<i>Pf</i>HRP2) antigenemia.

<p>A) ACTG 5208 study participant samples were censored to include only one malaria diagnosis per patient; B) ACTG 5208 study participant samples to include multiple episodes (only if separated by at least one malaria negative sample).</p